First cannabis-based medicines approved for reimbursement

Latest

First cannabis-based medicines approved for reimbursement

In Latest

Pharmacists in England are to be reimbursed for dispensing cannabis-based products for the first time.

Sativex contains CBD and THC and has been recommended for use on the NHS to treat MS-related spasticity, while CBD-containing Epidyolex has been recommended for seizures associated with Lennox Gastaut syndrome or Dravet syndrome.

Both are made by GW Pharmaceuticals, a specialist manufacturer of cannabis-based medicinal products (CBMPs).

The move came as NICE published its final CBMP guidelines, which in some respects depart from draft guidance issued in August.

Whereas previously the watchdog said CBMPs should not be used to treat MS-related spasticity because they were not judged to be cost-effective, it now recommends keeping patients on treatment if a four-week trial with Sativex spray leads to “at least a 20 per cent reduction in spasticity-related symptoms” where other treatments have failed.

NICE has decided to recommend Epidyolex following a price reduction by GW Pharmaceuticals, having previously said the medicine did not represent value for money. It has repeated its call for more research to be carried out to determine the clinical suitability and cost effectiveness of using CBMPs to treat severe epilepsy.

The watchdog’s position on using CBMPs to treat chronic pain – that this should only take place as part of a clinical trial – remains unchanged.

'Pharmacists on frontline'

Royal Pharmaceutical Society chief scientist Gino Martini said this was “excellent news for patients”, adding that the RPS agreed with NICE that “national registers of treatment with cannabis-based medicinal products should be set up to record evidence on clinical outcomes and adverse effects with prescribing in real-life situations”.

Mr Martini said: “Pharmacists will be on the frontline of supplying cannabis-based medicinal products and can give advice to patients on them as part of their treatment plan. It’s essential there is robust governance around prescribing and dispensing, and pharmacists have a key role to play in ensuring this is in place across health systems.

GW Pharmaceuticals commented: “This is proof that cannabis-based medicines can successfully go through extensive, randomised, placebo-controlled trials and a rigorous NICE evaluation process to reach patients.”

The news was met with mixed feelings by campaigners for medicinal cannabis. Genevieve Edwards of the MS Society said the Sativex recommendation showed “NICE has finally listened” but added: “These guidelines are an important first step, but don’t go far enough. No cannabis-based treatments have been recommended to treat pain, a common symptom of MS.”

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Latest

Quit smoking to improve mental health, urges charity

Smokers who quit for six weeks or more are happier and have better mental health than those who carry on smoking, new research shows. 

1 Min Article

bookmark_icon_off
Latest

More adults contacting drug and alcohol services

The number of adults using drug and alcohol treatment services in England rose slightly over 12 months.

1 Min Article

bookmark_icon_off
Latest

GPs ‘staggered’ by pharmacist antibiotics pilot

A pilot that saw pharmacists work with GP surgeries to reduce inappropriate antibiotic prescribing achieved “staggering” results.

1 Min Article

bookmark_icon_off
Latest

Avicenna branches up for auction weeks after acquisition

Fifteen pharmacies in Wales that were acquired by Avicenna in April are to be sold at auction next week.

1 Min Article

bookmark_icon_off
Latest

NHS to train community pharmacists in mental health drive

The Government has announced plans to train and recruit 50 community-based mental health pharmacists in England as part of the new NHS People Plan.

1 Min Article

bookmark_icon_off
Latest

Pharmacies receive £250 per hour to open on Friday bank holiday

NHSE&I announce the terms for opening on the May 8 bank holiday is the same as Good Friday and Easter Monday.

1 Min Article

Recommended Learning

bookmark_icon_off
Sponsored modules

This module will help the pharmacy team to understand erectile dysfunction and its causes, and supply Viagra Connect to male customers affected by it, where appropriate

10 Min Module

bookmark_icon_off
Videos

Advising on thrush treatment

This video looks at the distinctive benefits of different combination products and how to find the right treatment option for your customer.

7 Min Module

bookmark_icon_off
Sponsored modules

Relief from the nasal symptoms of allergy

With NHS England advising that OTC products should no longer be prescribed to treat mild-to-moderate hayfever, pharmacy’s role in supporting sufferers is more important than ever. This module includes self-care advice and product recommendations to aid customer conversations.

900 Min Module

bookmark_icon_off
Sponsored modules

Biological medicines and biosimilars

This module explores biological and biosimilar medicines, and will increase your understanding of the guidelines surrounding the brand prescribing of these drugs and your role in their supply

10 Min Module

bookmark_icon_off
News

Bacterial vaginosis (BV): Test and treat

This short module is designed to help you have conversations with customers about Canestest and Canesbalance Bacterial Vaginosis Vaginal Gel.

10 Min Module

bookmark_icon_off
Sponsored modules

Understanding abdominal pain, cramps and IBS

This short video explains the symptoms of irritable bowel syndrome (IBS) and how it differs from abdominal cramps to help you recommend a suitable product for your customer’s needs.

3 Min Module